Hiroaki Nagashima

Kobe, 6500017, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Long-term clinical outcomes and recurrence factors in intracranial germinoma.

Long-term clinical outcomes and recurrence factors in intracranial germinoma.

Journal: Journal of neuro-oncology

Published: April 23, 2026

Leptomeningeal Dissemination in TERT Promoter-mutant Anaplastic Pleomorphic Xanthoastrocytoma Responding to BRAF-MEK Inhibition: A Case Report.

Leptomeningeal Dissemination in TERT Promoter-mutant Anaplastic Pleomorphic Xanthoastrocytoma Responding to BRAF-MEK Inhibition: A Case Report.

Journal: NMC case report journal

Published: March 17, 2026

Intracranial solitary fibrous tumor with multiloculated cystic change: A case report.

Intracranial solitary fibrous tumor with multiloculated cystic change: A case report.

Journal: Radiology case reports

Published: February 09, 2026

Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.

Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.

Journal: Journal of neurology

Published: January 30, 2026

Clinical outcomes and MRI-based neurotoxicity assessment of elderly primary CNS lymphoma.

Clinical outcomes and MRI-based neurotoxicity assessment of elderly primary CNS lymphoma.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: January 28, 2026

CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway-altered.

CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway-altered.

Journal: Acta neuropathologica communications

Published: January 13, 2026

CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway-altered.

CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway-altered.

Journal: Acta neuropathologica communications

Published: January 13, 2026

High-risk morphology in cystic vestibular schwannomas: an imaging-based scoring system for facial nerve outcomes.

High-risk morphology in cystic vestibular schwannomas: an imaging-based scoring system for facial nerve outcomes.

Journal: Journal of neuro-oncology

Published: December 18, 2025

A pathologically diagnosed multinodular and vacuolating neuronal tumor without typical multiple nodules: a case report.

A pathologically diagnosed multinodular and vacuolating neuronal tumor without typical multiple nodules: a case report.

Journal: Frontiers in radiology

Published: October 04, 2025

Ketogenic diet therapy for high-grade gliomas combined with standard treatment using an angiogenesis inhibitor: An exploratory pilot study on feasibility.

Ketogenic diet therapy for high-grade gliomas combined with standard treatment using an angiogenesis inhibitor: An exploratory pilot study on feasibility.

Journal: Neuro-oncology advances

Published: September 25, 2025

Trilaminar DuraGen-Anchored Closure for Dural Repair in Posterior Fossa Surgery: Technical Note and Case Series.

Trilaminar DuraGen-Anchored Closure for Dural Repair in Posterior Fossa Surgery: Technical Note and Case Series.

Journal: Neurosurgery practice

Published: August 19, 2025

Tumor-associated M2 macrophages shape the cerebrospinal fluid immunoprofile, and the soluble CD163/type I interferon ratio correlates with prognosis in high grade glioma.

Tumor-associated M2 macrophages shape the cerebrospinal fluid immunoprofile, and the soluble CD163/type I interferon ratio correlates with prognosis in high grade glioma.

Journal: Journal of neuro-oncology

Published: August 19, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026